Best Life Sciences Tech Companies in Philadelphia, United States
The 32 best Life Sciences Tech companies in Philadelphia, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: iECURE.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Philadelphia
| # | Company | Last round | Disclosed funding | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Accencio Provider of software solutions for pharma companies to accelerate drug discovery process | — | — | 8 | Kevin Brogle Co-Founder | — | 16 patents Patents concentrated in health & consumer products | — |
| 2 | Cadient Digital marketing agency and analytics solutions | — | — | 16 | — | — | — | — |
| 3 | Clineage Provider of platform for clinical trial design and patient engagement | — | — | 7 | Joshua Horton Co-Founder and CEO | — | — | — |
| 4 | Clinical Trials iPhone app providing a detailed listing of NLM/NIH registered clinical trials for healthcare professionals | — | — | — | Geoffrey Young Founder & CTO | — | 36 patents Patient registry platforms, breast imaging technologies, antihistamine drugs, skin inflammation treatments | — |
| 5 | Datazymes | — | — | — | Amith Mohan Co-Founder & Director | Tailwind CSSEnvoyReact+2 | — | — |
| 6 | EDCsuite Software solutions for EDC, ePRO, IWRS and data management during clinical trials | — | — | — | Patrick Chevarier CEO | — | — | — |
| 7 | GeNovu Provider of laboratory information software | — | — | — | Kyle Cook CEO & CTO | — | — | — |
| 8 | globalsubmit GlobalSubmit is a software company. | — | — | 50 | — | — | 2 patents Supply chain provenance tracking and research protocol compliance data analytics | — |
Top 12 Life Sciences Tech companies in Philadelphia
#1
Series C · Philadelphia, Pennsylvania · founded 2014 · 85 employees$79.2Mraised▾
Proscia’s is a cloud-based software platform that clinic management, analysis, access, and collaboration for slide images in digital pathology. The features of the Proscia platform that allow users to improve whole slide image workflows include secure storage, annotation, and collaboration on digital biopsies. The company has developed a digital pathology platform called Concentriq that uses AI technology for computational pathology applications. The company has developed a tool that assists helathacre providers to diagnose cancer cells using image analysis technology.
- Mar 2025Series C$50M
- Dec 2023Series C$9M
- Jun 2022Series C$37M
- Nov 2020Series B$23M
#2
Series A · Philadelphia, Pennsylvania · founded 2019$4.5Mraised▾
Provider of AI operating system that accelerates the identification and development of the most promising drug candidates
- Mar 2025Series A$6.6M
- Nov 2023Seed$4.5M
#3
Series A · Philadelphia, Pennsylvania · founded 2020 · 7 employees$115Mraised▾
Online genetic engineering tool for drug development. The company focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases including ARCUS a mediated therapeutic candidate.
- Nov 2022Series A$65M
- Sep 2021Series A$50M
#4
Seed · Philadelphia, Pennsylvania · founded 2018 · 5 employees$5.7Mraised▾
Panorama Medicine provides drug discovery platform. The company designed a platform that integrates genomics, big data, and computing to develop therapeutic interventions for RNA defects in disease. The platform helps in end-to-end, data production and analysis through validation of discoveries.
- Sep 2023Grant (prize money)$333.8K
- Jan 2021Seed$2M
- Jun 2019Seed$3.7M
- Sep 2018Conventional Debt$500K
#5
Funding Raised · Philadelphia, Pennsylvania · founded 2020 · 5 employees$274.4Kraised▾
Provider of gene-editing platform for drug development. It offers a CasPlus platform that uses CRISPR based constructs to edit mutation responsible for monogenetic disorders for curative therapies for rare genetic disorders.
- Jun 2024Grant (prize money)$274.4K
#6
Series A · Philadelphia, Pennsylvania · founded 2017 · 10 employees$6.5Mraised▾
Provider of a cloud-based diagnostic platform for clinicians. The company leverages paper or wax-based platforms to create rapid, quantitative, assay-based (RQA) diagnostic tests to measure various human biosample specimens such as blood, saliva, and urine.
- Jul 2020Series A$655K
- Aug 2019Series A$959.2K
- Nov 2018Series A$4.5M
- Sep 2018Angel$425K
#7
Acquired · Philadelphia, Pennsylvania · founded 2001 · 28 employees$6Mraised▾
CFS Clinical (CFS) provides technology solutions and services focussed on financial management activities for clinical trials. It offers investigator site payment and study startup solutions. It claims that the solutions help accelerate cycle times, manage compliance and risk and strengthen Investigator relationships. Technology platforms include CFS Startup InSite - Study start up solutions and CFS Payment InSite - investigator payment solution. The company has been acquired by Drug Dev and both the platforms have been integrated as a part of Drug Dev's offerings.
- 2004Unattributed—
- 2001Conventional Debt$6M
#8
Funding Raised · Philadelphia, Pennsylvania · founded 2015$447.8Kraised▾
Biosignal Analytics offers a tool to automatically label and enhance EEG signals. The company uses machine learning algorithms to develop this automated interpretation technology. The tool enables real-time alerting and generates a diagnostic report.
- Jul 2016Grant (prize money)$223.9K
- 2016Grant (prize money)$223.9K
#9
Seed · Philadelphia, Pennsylvania · founded 2016 · 17 employees$150Kraised▾
Accelerating clinical research enrollment through patient-centric solutions and supportive communities. This platform connects patients with clinical studies, offering resources for both participants and sponsors. It provides a direct-to-patient enrollment approach, featuring condition-specific communities, patient stories, and investigator profiles. The company aims to accelerate study timelines by offering solutions for sponsors, CROs, and research sites. It serves as a clinical research education hub, offering a blog with innovative strategies and expert insights. The platform facilitates access to featured studies actively seeking participants across various conditions. It offers a supportive environment for patients to learn about clinical research and find relevant studies. The company's solutions are designed to improve patient access to clinical trials and accelerate the development of new therapies.
- Mar 2017Seed$150K
#10
Seed · Philadelphia, Pennsylvania · founded 2010$50Kraised▾
CytoVas, a spin-out from Univ. of Pennsylvania, is developing a proprietary cell-based informatics platform, CLOUD CYTOMICS, that is advancing precision medicine by providing clinicians and drug developers with actionable information on novel cellular markers of disease progression and individual treatment response. The company’s technology enables it to mine flow cytometry data to rapidly identify and automate the interpretation of novel cellular biomarkers. This approach enables clients to make critical decisions in their efforts to develop and deliver safer, more precisely targeted therapies for patients. CLOUD CYTOMICS is broadly applicable across therapeutic areas and disease states and used throughout all stages of drug development. CytoVas is currently working with partners to exploit the technology’s potential in Cardiovascular Disease, Type 2 Diabetes, Preeclampsia, Alzheimer’s, Acute Myeloid Leukemia, Psoriasis, Rheumatoid Arthritis, and Peripheral Arterial Disease. Future studies are planned in Traumatic Brain Injury. In Apr 2013, the company entered into a partnership with Becton Dickinson Biosciences to develop a blood-based diagnostic test for predicting a patient's r
- Aug 2017Seed$50K
- Mar 2014Grant (prize money)$222.9K
- Sep 2013Grant (prize money)$271.3K
#11
Deadpooled · Philadelphia, Pennsylvania · founded 2015 · 5 employees$62Kraised▾
Connecting donors with researchers to accelerate genetic research and cures. This platform acts as a matchmaker, connecting individuals willing to donate DNA samples with researchers seeking specific genetic profiles for their studies. Donors create free accounts, provide basic demographic and medical information, and are notified when they match a research study. Participation is voluntary, and donors are compensated for their contributions, promoting fair exchange for valuable genetic material. The process ensures donor privacy through de-identification. This innovative model aims to speed up genetic research, leading to faster discovery of treatments and cures for various diseases. It is a B2B and B2C platform, impacting healthcare and research. The website offers features like sign-up, login, FAQs, press releases, blog, contact, legal information, privacy policy, and terms & conditions. It is a tech-enabled service facilitating genetic donations.
- Feb 2016Seed$50K
- Aug 2015Seed$12K
#12
Seed · Philadelphia, Pennsylvania · founded 2012—raised▾
OncoStem Biotherapeutics is developing small molecule based therapeutics for cancer treatment. It is a Biotech company with a proprietary database of unique cancer-causing genes identified through Genomics, Bioinformatics, Systems Biology, and Network Theory approaches, coupled with the company's extensive expertise in bioassays, revealing unique cancer gene targets for the development of a whole new class of personalized cancer drugs. The company has partnered with a number of academic and commercial entities, like NAL Pharma, Columbia University, ICAN etc. to develop and commercialize drugs based on their target collection.
- Dec 2013Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Philadelphia researches in biotechnology
- Children\'s Hospital of Philadelphia31
- Philadelphia University5
- Philadelphia College of Osteopathic Medicine2
- Einstein Medical Center Philadelphia1
- Philadelphia VA Medical Center1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.